Bay­er's re­struc­tur­ing hits phar­ma lead­er­ship, shift­ing about half of ex­ecs off top team

Bay­er is “ba­si­cal­ly halv­ing” the size of its phar­ma­ceu­ti­cal lead­er­ship team, a spokesper­son told End­points News, as the com­pa­ny be­gins to roll out a re­struc­tur­ing plan aimed at mak­ing it more ef­fi­cient.

The Ger­man drug­mak­er is elim­i­nat­ing six seats on the phar­ma­ceu­ti­cal di­vi­sion’s lead­er­ship team, though on­ly one ex­ec­u­tive is leav­ing the com­pa­ny, the spokesper­son said Wednes­day. The cur­rent lead­er­ship team is made up of 14 ex­ec­u­tives, in­clud­ing lead­ers from com­mu­ni­ca­tions, le­gal and HR who are not af­fect­ed by the lat­est changes. Anne-Grethe Mortensen, head of glob­al mar­ket­ing, is leav­ing the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER